Akero Therapeutics, Inc. (AKRO) Investor Notice: Robbins LLP Reminds Stockholders of the Akero Therapeutics, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)---- $AKRO #AKRO--Robbins LLP Investigates Allegations that Akero Therapeutics, Inc. (AKRO) Misled Investors Regarding Viability and Efficacy of its Drug Candidate